Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cytoplasmic membrane and cell wall are essential structural layers that protect prokaryotic and fungal cells from environmental stress and osmotic lysis. The cell wall provides mechanical rigidity through complex polymers like peptidoglycan in bacteria or chitin and glucans in fungi, while the underlying cytoplasmic membrane serves as a selective barrier and a site for critical metabolic processes, including energy production and signal transduction [1, 2, 3, 7]. These structures are premier targets for antimicrobial therapy because they contain unique molecular features—such as D-amino acids and ergosterol—that are absent in human cells, enabling high selective toxicity [10, 11, 12]. Antibiotics like beta-lactams and glycopeptides disrupt cell wall synthesis, leading to rapid bactericidal effects, whereas membrane-targeting agents like polymyxins and lipopeptides compromise the lipid bilayer's integrity to cause lethal ion leakage [5, 6, 9]. Despite their historical success, the clinical utility of drugs hitting these targets is increasingly challenged by the evolution of resistance mechanisms, such as target site modification and enzymatic inactivation [1, 13, 15].
Inhibition of peptidoglycan synthesis (transpeptidation and transglycosylation), disruption of membrane integrity via pore formation or detergent-like action, inhibition of beta-glucan synthesis, and binding to membrane sterols to increase permeability.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cytoplasmic membrane and cell wall.